Effects of repeated systemic administration of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) on striatal tyrosine hydroxylase activity in vitro and tyrosine hydroxylase content

Neurosci Lett. 1987 Sep 23;80(2):213-8. doi: 10.1016/0304-3940(87)90656-2.

Abstract

We examined both in vitro tyrosine hydroxylase (TH) activity and TH content determined by a new enzyme immunoassay in the mouse striatum after repeated systemic injection of MPTP. Repeated systemic administration of MPTP to mice (30 mg/kg per day, subcutaneously for 8 days) caused an approximately 65% decrease of both TH activity and TH content in the striatum. The intensity of immunohistochemical staining of TH protein in the striatum was also reduced in MPTP-treated mice. These results indicate that the reduction of TH activity in vitro after the repeated administration of MPTP is due to reduction of TH protein as a result of nerve degeneration.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine
  • Animals
  • Corpus Striatum / drug effects
  • Corpus Striatum / enzymology*
  • Dopamine / metabolism
  • Immunohistochemistry
  • Immunologic Techniques
  • In Vitro Techniques
  • Male
  • Mice
  • Mice, Inbred C57BL
  • Pyridines / administration & dosage*
  • Pyridines / pharmacology
  • Tyrosine 3-Monooxygenase / metabolism*

Substances

  • Pyridines
  • 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine
  • Tyrosine 3-Monooxygenase
  • Dopamine